nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—PPARG—malignant glioma	0.474	0.575	CbGaD
Nateglinide—PTGS1—malignant glioma	0.35	0.425	CbGaD
Nateglinide—SLC15A2—choroid plexus—malignant glioma	0.0123	0.208	CbGeAlD
Nateglinide—ORM1—vertebral column—malignant glioma	0.00593	0.1	CbGeAlD
Nateglinide—PPARG—endothelium—malignant glioma	0.00246	0.0417	CbGeAlD
Nateglinide—PPARG—blood vessel—malignant glioma	0.00227	0.0384	CbGeAlD
Nateglinide—ABCC8—brainstem—malignant glioma	0.00163	0.0275	CbGeAlD
Nateglinide—ABCC8—telencephalon—malignant glioma	0.00144	0.0244	CbGeAlD
Nateglinide—SLC16A1—retina—malignant glioma	0.00143	0.0242	CbGeAlD
Nateglinide—PPARG—embryo—malignant glioma	0.00136	0.0229	CbGeAlD
Nateglinide—PTGS1—endothelium—malignant glioma	0.00132	0.0223	CbGeAlD
Nateglinide—SLC16A1—telencephalon—malignant glioma	0.00131	0.0222	CbGeAlD
Nateglinide—PTGS1—blood vessel—malignant glioma	0.00122	0.0205	CbGeAlD
Nateglinide—ABCC8—medulla oblongata—malignant glioma	0.00113	0.0192	CbGeAlD
Nateglinide—Mitiglinide—PPARG—malignant glioma	0.00111	0.246	CrCbGaD
Nateglinide—ABCC8—midbrain—malignant glioma	0.00104	0.0175	CbGeAlD
Nateglinide—SLC16A1—medulla oblongata—malignant glioma	0.00103	0.0175	CbGeAlD
Nateglinide—ABCC8—spinal cord—malignant glioma	0.00101	0.0171	CbGeAlD
Nateglinide—Ramipril—BCHE—malignant glioma	0.001	0.222	CrCbGaD
Nateglinide—SLC16A1—midbrain—malignant glioma	0.000944	0.016	CbGeAlD
Nateglinide—SLC15A2—retina—malignant glioma	0.000939	0.0159	CbGeAlD
Nateglinide—SLC16A1—spinal cord—malignant glioma	0.000921	0.0156	CbGeAlD
Nateglinide—KCNJ11—central nervous system—malignant glioma	0.000891	0.0151	CbGeAlD
Nateglinide—KCNJ11—cerebellum—malignant glioma	0.000871	0.0147	CbGeAlD
Nateglinide—SLC15A2—telencephalon—malignant glioma	0.000863	0.0146	CbGeAlD
Nateglinide—ORM1—spinal cord—malignant glioma	0.000826	0.014	CbGeAlD
Nateglinide—ABCC8—central nervous system—malignant glioma	0.000821	0.0139	CbGeAlD
Nateglinide—Bortezomib—PTGS1—malignant glioma	0.000813	0.18	CrCbGaD
Nateglinide—ABCC8—cerebellum—malignant glioma	0.000803	0.0136	CbGeAlD
Nateglinide—SLC22A6—brain—malignant glioma	0.000749	0.0127	CbGeAlD
Nateglinide—SLC16A1—central nervous system—malignant glioma	0.000747	0.0126	CbGeAlD
Nateglinide—SLC16A1—cerebellum—malignant glioma	0.00073	0.0123	CbGeAlD
Nateglinide—KCNJ11—brain—malignant glioma	0.000708	0.012	CbGeAlD
Nateglinide—SLC15A2—medulla oblongata—malignant glioma	0.000678	0.0115	CbGeAlD
Nateglinide—ORM1—central nervous system—malignant glioma	0.00067	0.0113	CbGeAlD
Nateglinide—ABCC8—brain—malignant glioma	0.000652	0.011	CbGeAlD
Nateglinide—PPARG—central nervous system—malignant glioma	0.000627	0.0106	CbGeAlD
Nateglinide—Dextroamphetamine—SLC6A3—malignant glioma	0.000623	0.138	CrCbGaD
Nateglinide—SLC15A2—midbrain—malignant glioma	0.00062	0.0105	CbGeAlD
Nateglinide—SLC15A2—spinal cord—malignant glioma	0.000605	0.0102	CbGeAlD
Nateglinide—SLC16A1—brain—malignant glioma	0.000593	0.01	CbGeAlD
Nateglinide—PTGS1—telencephalon—malignant glioma	0.000589	0.00997	CbGeAlD
Nateglinide—ABCC4—central nervous system—malignant glioma	0.000569	0.00962	CbGeAlD
Nateglinide—CYP2D6—brainstem—malignant glioma	0.000546	0.00923	CbGeAlD
Nateglinide—Amphetamine—SLC6A3—malignant glioma	0.000502	0.111	CrCbGaD
Nateglinide—PPARG—brain—malignant glioma	0.000498	0.00841	CbGeAlD
Nateglinide—SLC15A2—central nervous system—malignant glioma	0.000491	0.0083	CbGeAlD
Nateglinide—CYP2D6—telencephalon—malignant glioma	0.000485	0.00819	CbGeAlD
Nateglinide—SLC15A2—cerebellum—malignant glioma	0.00048	0.00811	CbGeAlD
Nateglinide—ALB—brain—malignant glioma	0.000467	0.00789	CbGeAlD
Nateglinide—Methamphetamine—SLC6A3—malignant glioma	0.000466	0.103	CrCbGaD
Nateglinide—ABCC4—brain—malignant glioma	0.000452	0.00764	CbGeAlD
Nateglinide—Hepatic enzyme increased—Temozolomide—malignant glioma	0.000427	0.0571	CcSEcCtD
Nateglinide—PTGS1—spinal cord—malignant glioma	0.000413	0.00698	CbGeAlD
Nateglinide—SLC15A2—brain—malignant glioma	0.00039	0.00659	CbGeAlD
Nateglinide—PTGS1—central nervous system—malignant glioma	0.000335	0.00567	CbGeAlD
Nateglinide—Injury—Carmustine—malignant glioma	0.00033	0.0442	CcSEcCtD
Nateglinide—Thirst—Temozolomide—malignant glioma	0.000308	0.0412	CcSEcCtD
Nateglinide—CYP3A4—central nervous system—malignant glioma	0.00028	0.00473	CbGeAlD
Nateglinide—CYP2D6—central nervous system—malignant glioma	0.000275	0.00466	CbGeAlD
Nateglinide—CYP2D6—cerebellum—malignant glioma	0.000269	0.00455	CbGeAlD
Nateglinide—PTGS1—brain—malignant glioma	0.000266	0.0045	CbGeAlD
Nateglinide—Sweating increased—Temozolomide—malignant glioma	0.000247	0.033	CcSEcCtD
Nateglinide—Bronchitis—Temozolomide—malignant glioma	0.000244	0.0326	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000236	0.0315	CcSEcCtD
Nateglinide—Neuropathy peripheral—Carmustine—malignant glioma	0.000229	0.0307	CcSEcCtD
Nateglinide—Neuropathy peripheral—Temozolomide—malignant glioma	0.000222	0.0296	CcSEcCtD
Nateglinide—CYP2D6—brain—malignant glioma	0.000219	0.0037	CbGeAlD
Nateglinide—Hepatobiliary disease—Temozolomide—malignant glioma	0.000214	0.0286	CcSEcCtD
Nateglinide—Oedema peripheral—Carmustine—malignant glioma	0.000207	0.0277	CcSEcCtD
Nateglinide—Oedema peripheral—Temozolomide—malignant glioma	0.0002	0.0267	CcSEcCtD
Nateglinide—Erythema multiforme—Temozolomide—malignant glioma	0.000192	0.0257	CcSEcCtD
Nateglinide—Immune system disorder—Temozolomide—malignant glioma	0.000183	0.0245	CcSEcCtD
Nateglinide—Malnutrition—Carmustine—malignant glioma	0.000183	0.0244	CcSEcCtD
Nateglinide—Back pain—Carmustine—malignant glioma	0.000177	0.0237	CcSEcCtD
Nateglinide—Malnutrition—Temozolomide—malignant glioma	0.000177	0.0236	CcSEcCtD
Nateglinide—Tremor—Carmustine—malignant glioma	0.000171	0.0229	CcSEcCtD
Nateglinide—Back pain—Temozolomide—malignant glioma	0.000171	0.0229	CcSEcCtD
Nateglinide—Tremor—Temozolomide—malignant glioma	0.000166	0.0221	CcSEcCtD
Nateglinide—Palpitations—Temozolomide—malignant glioma	0.000156	0.0209	CcSEcCtD
Nateglinide—Cough—Temozolomide—malignant glioma	0.000154	0.0206	CcSEcCtD
Nateglinide—Hyperhidrosis—Temozolomide—malignant glioma	0.000139	0.0186	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Carmustine—malignant glioma	0.000129	0.0172	CcSEcCtD
Nateglinide—Dyspepsia—Temozolomide—malignant glioma	0.000127	0.017	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000124	0.0166	CcSEcCtD
Nateglinide—Fatigue—Temozolomide—malignant glioma	0.000124	0.0166	CcSEcCtD
Nateglinide—Gastrointestinal pain—Carmustine—malignant glioma	0.000122	0.0163	CcSEcCtD
Nateglinide—Abdominal pain—Carmustine—malignant glioma	0.000118	0.0158	CcSEcCtD
Nateglinide—Gastrointestinal pain—Temozolomide—malignant glioma	0.000118	0.0158	CcSEcCtD
Nateglinide—Urticaria—Temozolomide—malignant glioma	0.000115	0.0153	CcSEcCtD
Nateglinide—Abdominal pain—Temozolomide—malignant glioma	0.000114	0.0152	CcSEcCtD
Nateglinide—Hypersensitivity—Carmustine—malignant glioma	0.00011	0.0147	CcSEcCtD
Nateglinide—Asthenia—Carmustine—malignant glioma	0.000107	0.0143	CcSEcCtD
Nateglinide—Hypersensitivity—Temozolomide—malignant glioma	0.000106	0.0142	CcSEcCtD
Nateglinide—Asthenia—Temozolomide—malignant glioma	0.000103	0.0138	CcSEcCtD
Nateglinide—Diarrhoea—Carmustine—malignant glioma	0.000102	0.0137	CcSEcCtD
Nateglinide—Pruritus—Temozolomide—malignant glioma	0.000102	0.0136	CcSEcCtD
Nateglinide—Dizziness—Carmustine—malignant glioma	9.87e-05	0.0132	CcSEcCtD
Nateglinide—Diarrhoea—Temozolomide—malignant glioma	9.87e-05	0.0132	CcSEcCtD
Nateglinide—Dizziness—Temozolomide—malignant glioma	9.54e-05	0.0128	CcSEcCtD
Nateglinide—Vomiting—Carmustine—malignant glioma	9.49e-05	0.0127	CcSEcCtD
Nateglinide—Rash—Carmustine—malignant glioma	9.41e-05	0.0126	CcSEcCtD
Nateglinide—Dermatitis—Carmustine—malignant glioma	9.4e-05	0.0126	CcSEcCtD
Nateglinide—Vomiting—Temozolomide—malignant glioma	9.17e-05	0.0123	CcSEcCtD
Nateglinide—Rash—Temozolomide—malignant glioma	9.09e-05	0.0122	CcSEcCtD
Nateglinide—Dermatitis—Temozolomide—malignant glioma	9.08e-05	0.0121	CcSEcCtD
Nateglinide—Nausea—Carmustine—malignant glioma	8.86e-05	0.0119	CcSEcCtD
Nateglinide—Nausea—Temozolomide—malignant glioma	8.57e-05	0.0115	CcSEcCtD
Nateglinide—PTGS1—Metabolism—GSTT1—malignant glioma	2.21e-05	0.000209	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.2e-05	0.000209	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—BCAN—malignant glioma	2.2e-05	0.000209	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—MYC—malignant glioma	2.19e-05	0.000208	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VEGFA—malignant glioma	2.18e-05	0.000207	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GSTP1—malignant glioma	2.18e-05	0.000207	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—BCAN—malignant glioma	2.18e-05	0.000207	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.18e-05	0.000207	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CAV1—malignant glioma	2.18e-05	0.000207	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	2.16e-05	0.000205	CbGpPWpGaD
Nateglinide—ALB—Metabolism—IDH2—malignant glioma	2.15e-05	0.000204	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—IDH1—malignant glioma	2.15e-05	0.000203	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS1—malignant glioma	2.13e-05	0.000202	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CAT—malignant glioma	2.12e-05	0.000201	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CG—malignant glioma	2.08e-05	0.000197	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SPHK1—malignant glioma	2.08e-05	0.000197	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.06e-05	0.000195	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP2C18—malignant glioma	2.03e-05	0.000193	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.03e-05	0.000192	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP2B6—malignant glioma	2.02e-05	0.000192	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—EGFR—malignant glioma	2.02e-05	0.000191	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CG—malignant glioma	2.02e-05	0.000191	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—NCOR1—malignant glioma	2.01e-05	0.00019	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PPARG—malignant glioma	2.01e-05	0.00019	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CG—malignant glioma	1.99e-05	0.000188	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—BCHE—malignant glioma	1.98e-05	0.000188	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—NOTCH1—malignant glioma	1.96e-05	0.000186	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SLC5A5—malignant glioma	1.96e-05	0.000186	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PPARG—malignant glioma	1.95e-05	0.000184	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—BCHE—malignant glioma	1.92e-05	0.000182	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TNF—malignant glioma	1.92e-05	0.000182	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	1.92e-05	0.000182	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PPARG—malignant glioma	1.92e-05	0.000182	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PDGFB—malignant glioma	1.91e-05	0.000182	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—KRAS—malignant glioma	1.9e-05	0.000181	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.9e-05	0.00018	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SLC5A5—malignant glioma	1.9e-05	0.00018	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GSTP1—malignant glioma	1.88e-05	0.000178	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—AKT1—malignant glioma	1.87e-05	0.000177	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—KRAS—malignant glioma	1.86e-05	0.000176	CbGpPWpGaD
Nateglinide—ALB—Metabolism—IDH1—malignant glioma	1.85e-05	0.000175	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CD—malignant glioma	1.83e-05	0.000173	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CAT—malignant glioma	1.83e-05	0.000173	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—CAV1—malignant glioma	1.81e-05	0.000172	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—COX8A—malignant glioma	1.8e-05	0.000171	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.8e-05	0.00017	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SPHK1—malignant glioma	1.79e-05	0.00017	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.78e-05	0.000169	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—IDH2—malignant glioma	1.77e-05	0.000168	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CD—malignant glioma	1.77e-05	0.000168	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—IDH2—malignant glioma	1.76e-05	0.000167	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP2C18—malignant glioma	1.75e-05	0.000166	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CD—malignant glioma	1.75e-05	0.000166	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—FN1—malignant glioma	1.73e-05	0.000164	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—F2—malignant glioma	1.73e-05	0.000164	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NCOR1—malignant glioma	1.72e-05	0.000163	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PIK3CA—malignant glioma	1.71e-05	0.000162	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.67e-05	0.000158	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.66e-05	0.000157	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.65e-05	0.000157	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CG—malignant glioma	1.65e-05	0.000157	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.65e-05	0.000157	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—malignant glioma	1.65e-05	0.000157	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTT1—malignant glioma	1.65e-05	0.000156	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CAV1—malignant glioma	1.64e-05	0.000155	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—EGF—malignant glioma	1.63e-05	0.000155	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PTPN11—malignant glioma	1.62e-05	0.000154	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CB—malignant glioma	1.59e-05	0.000151	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTGS2—malignant glioma	1.58e-05	0.00015	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GSTP1—malignant glioma	1.58e-05	0.00015	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.56e-05	0.000148	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.55e-05	0.000147	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CB—malignant glioma	1.54e-05	0.000146	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS1—malignant glioma	1.54e-05	0.000146	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CAT—malignant glioma	1.54e-05	0.000146	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ASMT—malignant glioma	1.53e-05	0.000145	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—malignant glioma	1.53e-05	0.000145	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GSTP1—malignant glioma	1.53e-05	0.000145	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—IDH1—malignant glioma	1.53e-05	0.000145	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CB—malignant glioma	1.52e-05	0.000144	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—IDH1—malignant glioma	1.51e-05	0.000143	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT2—malignant glioma	1.51e-05	0.000143	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTGS2—malignant glioma	1.51e-05	0.000143	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.5e-05	0.000143	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.5e-05	0.000142	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CG—malignant glioma	1.49e-05	0.000141	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CAT—malignant glioma	1.49e-05	0.000141	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SPHK1—malignant glioma	1.48e-05	0.00014	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SPHK1—malignant glioma	1.46e-05	0.000139	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CD—malignant glioma	1.45e-05	0.000138	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.45e-05	0.000138	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NCOR1—malignant glioma	1.45e-05	0.000137	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.45e-05	0.000137	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—BCAN—malignant glioma	1.44e-05	0.000136	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.43e-05	0.000136	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—BCHE—malignant glioma	1.43e-05	0.000136	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—AKT1—malignant glioma	1.43e-05	0.000136	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTT1—malignant glioma	1.42e-05	0.000134	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.42e-05	0.000134	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CAV1—malignant glioma	1.41e-05	0.000133	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NCOR1—malignant glioma	1.41e-05	0.000133	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—AKT1—malignant glioma	1.39e-05	0.000132	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTEN—malignant glioma	1.38e-05	0.00013	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.35e-05	0.000128	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.34e-05	0.000127	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTEN—malignant glioma	1.33e-05	0.000127	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS1—malignant glioma	1.33e-05	0.000126	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.32e-05	0.000125	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTEN—malignant glioma	1.32e-05	0.000125	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CD—malignant glioma	1.31e-05	0.000124	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—RAF1—malignant glioma	1.3e-05	0.000123	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CG—malignant glioma	1.28e-05	0.000121	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CB—malignant glioma	1.27e-05	0.00012	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PPARG—malignant glioma	1.24e-05	0.000117	CbGpPWpGaD
Nateglinide—ALB—Metabolism—BCHE—malignant glioma	1.23e-05	0.000117	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.23e-05	0.000117	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.22e-05	0.000116	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SLC5A5—malignant glioma	1.22e-05	0.000116	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.19e-05	0.000113	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CAV1—malignant glioma	1.18e-05	0.000112	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTT1—malignant glioma	1.17e-05	0.000111	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IL2—malignant glioma	1.16e-05	0.00011	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—IDH2—malignant glioma	1.16e-05	0.00011	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTT1—malignant glioma	1.16e-05	0.00011	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.15e-05	0.000109	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CAV1—malignant glioma	1.15e-05	0.000109	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.14e-05	0.000108	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CB—malignant glioma	1.14e-05	0.000108	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GSTP1—malignant glioma	1.14e-05	0.000108	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—malignant glioma	1.13e-05	0.000107	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CD—malignant glioma	1.13e-05	0.000107	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	1.12e-05	0.000106	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CAT—malignant glioma	1.11e-05	0.000105	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS1—malignant glioma	1.1e-05	0.000104	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.09e-05	0.000104	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.09e-05	0.000103	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS1—malignant glioma	1.09e-05	0.000103	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.08e-05	0.000103	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CG—malignant glioma	1.08e-05	0.000102	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—malignant glioma	1.05e-05	9.99e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NCOR1—malignant glioma	1.05e-05	9.94e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CG—malignant glioma	1.04e-05	9.89e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPARG—malignant glioma	1.04e-05	9.85e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—BCHE—malignant glioma	1.02e-05	9.66e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—BCHE—malignant glioma	1.01e-05	9.58e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARG—malignant glioma	1.01e-05	9.55e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.01e-05	9.55e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC5A5—malignant glioma	9.98e-06	9.46e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—IDH1—malignant glioma	9.98e-06	9.46e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.96e-06	9.45e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—malignant glioma	9.88e-06	9.37e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTEN—malignant glioma	9.86e-06	9.35e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GSTP1—malignant glioma	9.82e-06	9.31e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CB—malignant glioma	9.81e-06	9.3e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—malignant glioma	9.72e-06	9.21e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CA—malignant glioma	9.71e-06	9.21e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SPHK1—malignant glioma	9.65e-06	9.15e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CAT—malignant glioma	9.56e-06	9.06e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CD—malignant glioma	9.46e-06	8.97e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.46e-06	8.97e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.44e-06	8.95e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CA—malignant glioma	9.41e-06	8.93e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.35e-06	8.87e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CA—malignant glioma	9.28e-06	8.8e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CD—malignant glioma	9.17e-06	8.7e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NCOR1—malignant glioma	9.02e-06	8.56e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CAV1—malignant glioma	8.54e-06	8.1e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTEN—malignant glioma	8.47e-06	8.04e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—KRAS—malignant glioma	8.4e-06	7.97e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CB—malignant glioma	8.25e-06	7.82e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—malignant glioma	8.17e-06	7.75e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.16e-06	7.73e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GSTP1—malignant glioma	8.11e-06	7.69e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GSTP1—malignant glioma	8.04e-06	7.62e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CB—malignant glioma	7.99e-06	7.58e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—malignant glioma	7.93e-06	7.52e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—malignant glioma	7.92e-06	7.51e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CAT—malignant glioma	7.89e-06	7.48e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CAT—malignant glioma	7.82e-06	7.42e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CG—malignant glioma	7.78e-06	7.38e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CA—malignant glioma	7.72e-06	7.32e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—malignant glioma	7.69e-06	7.29e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTT1—malignant glioma	7.65e-06	7.25e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—malignant glioma	7.58e-06	7.19e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARG—malignant glioma	7.51e-06	7.12e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—malignant glioma	7.47e-06	7.08e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NCOR1—malignant glioma	7.45e-06	7.07e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NCOR1—malignant glioma	7.39e-06	7e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CAV1—malignant glioma	7.36e-06	6.98e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—malignant glioma	7.31e-06	6.93e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS1—malignant glioma	7.17e-06	6.8e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTEN—malignant glioma	7.13e-06	6.76e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.03e-06	6.67e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CA—malignant glioma	6.96e-06	6.6e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTEN—malignant glioma	6.91e-06	6.55e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CD—malignant glioma	6.84e-06	6.49e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CG—malignant glioma	6.7e-06	6.35e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—BCHE—malignant glioma	6.66e-06	6.32e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.58e-06	6.24e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARG—malignant glioma	6.47e-06	6.13e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—malignant glioma	6.31e-06	5.98e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CAV1—malignant glioma	6.07e-06	5.76e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CAV1—malignant glioma	6.02e-06	5.71e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CA—malignant glioma	5.98e-06	5.67e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CB—malignant glioma	5.96e-06	5.65e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—malignant glioma	5.91e-06	5.6e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CD—malignant glioma	5.89e-06	5.59e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.75e-06	5.46e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—malignant glioma	5.68e-06	5.39e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.53e-06	5.25e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.49e-06	5.2e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARG—malignant glioma	5.34e-06	5.06e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GSTP1—malignant glioma	5.3e-06	5.03e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARG—malignant glioma	5.29e-06	5.02e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CAT—malignant glioma	5.16e-06	4.89e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTEN—malignant glioma	5.15e-06	4.89e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CB—malignant glioma	5.13e-06	4.87e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—malignant glioma	5.09e-06	4.82e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CA—malignant glioma	5.03e-06	4.77e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—malignant glioma	4.88e-06	4.63e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CA—malignant glioma	4.87e-06	4.62e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NCOR1—malignant glioma	4.87e-06	4.62e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.86e-06	4.61e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.82e-06	4.57e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTEN—malignant glioma	4.44e-06	4.21e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.24e-06	4.02e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.2e-06	3.99e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—malignant glioma	4.2e-06	3.98e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—malignant glioma	4.16e-06	3.95e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—malignant glioma	4.11e-06	3.9e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—malignant glioma	3.98e-06	3.78e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CAV1—malignant glioma	3.97e-06	3.77e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTEN—malignant glioma	3.66e-06	3.47e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.63e-06	3.45e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTEN—malignant glioma	3.63e-06	3.44e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.62e-06	3.43e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARG—malignant glioma	3.49e-06	3.31e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.18e-06	3.02e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CA—malignant glioma	3.13e-06	2.97e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—malignant glioma	2.97e-06	2.82e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.77e-06	2.63e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—malignant glioma	2.75e-06	2.6e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.58e-06	2.45e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.56e-06	2.43e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—malignant glioma	2.56e-06	2.42e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTEN—malignant glioma	2.4e-06	2.27e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—malignant glioma	2.11e-06	2e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—malignant glioma	2.09e-06	1.98e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.69e-06	1.6e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—malignant glioma	1.38e-06	1.31e-05	CbGpPWpGaD
